HomeComparePMBC vs JNJ

PMBC vs JNJ: Dividend Comparison 2026

PMBC yields 1.06% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $9.1K in total portfolio value· pulled ahead in Year 6
10 years
PMBC
PMBC
● Live price
1.06%
Share price
$9.40
Annual div
$0.10
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$113.99
Full PMBC calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — PMBC vs JNJ

📍 JNJ pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPMBCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PMBC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PMBC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PMBC
Annual income on $10K today (after 15% tax)
$90.43/yr
After 10yr DRIP, annual income (after tax)
$96.89/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,889.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PMBC + JNJ for your $10,000?

PMBC: 50%JNJ: 50%
100% JNJ50/50100% PMBC
Portfolio after 10yr
$25.7K
Annual income
$2,401.69/yr
Blended yield
9.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PMBC
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PMBC buys
0
JNJ buys
0
No recent congressional trades found for PMBC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPMBCJNJ
Forward yield1.06%2.13%
Annual dividend / share$0.10$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$21.2K$30.3K
Annual income after 10y$113.99$4,689.40
Total dividends collected$1.1K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: PMBC vs JNJ ($10,000, DRIP)

YearPMBC PortfolioPMBC Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,806$106.38$10,592$272.30+$214.00PMBC
2$11,670$107.44$11,289$357.73+$381.00PMBC
3$12,596$108.44$12,123$472.89+$473.00PMBC
4$13,587$109.38$13,141$629.86+$446.00PMBC
5$14,648$110.27$14,408$846.81+$240.00PMBC
6← crossover$15,785$111.10$16,021$1,151.60$236.00JNJ
7$17,001$111.89$18,122$1,588.22$1.1KJNJ
8$18,304$112.63$20,930$2,228.20$2.6KJNJ
9$19,699$113.33$24,792$3,191.91$5.1KJNJ
10$21,192$113.99$30,274$4,689.40$9.1KJNJ

PMBC vs JNJ: Complete Analysis 2026

PMBCStock

Pacific Mercantile Bancorp is a holding company of Pacific Mercantile Bank, which engages in the provision of banking services. The company is headquartered in Costa Mesa, California and currently employs 160 full-time employees. The firm's business operations are conducted by the Bank. The company operates through commercial banking segment. The Bank offers its customers different loan products, including commercial loans and credit lines, accounts receivable and inventory financing, Small Business Administration (SBA) guaranteed business loans, and owner-occupied commercial real estate loans. Its investments primarily include securities available for sale, which consist of residential mortgage backed securities issued by the United States agencies; residential collateralized mortgage obligations issued by non agencies; asset backed security and mutual funds. Its sources of funds include deposits, and borrowings and contractual obligations. Its deposits consist of noninterest bearing demand deposits, interest-bearing checking accounts, money market and savings deposits, and time deposits.

Full PMBC Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PMBC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PMBC vs SCHDPMBC vs JEPIPMBC vs OPMBC vs KOPMBC vs MAINPMBC vs ABBVPMBC vs MRKPMBC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.